CrownWheel collaborates with healthcare companies, academic institutions and inventors to provide creative and flexible structures to meet their unique financing needs. These structures include monetization of royalty streams, revenue participation, and the purchase of structured debt and equity. CrownWheel also participates in the acquisition of legacy products from companies seeking to divest non-core assets.
Our team has substantial experience in healthcare principal investing, operations, and strategy which provides us with a unique perspective on investment opportunities in the life sciences.
CrownWheel is backed by Longitude Capital, a leading investment firm with over $1.2 billion under management that focuses on venture growth and growth equity investments in the life sciences industry.